Austell-Paracetamol

Quick links

Choose a section

Quick links to important sections

Advertisements

Austell-Paracetamol

Advertisements
Advertisements

Overview of Austell-Paracetamol

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Pharmacological Class Non-opioid analgesic and Antipyretic
Common Use Relief of pain and fever
Origin Synthetic compound
Standard Forms Tablets, caplets, oral suspension

What is Austell-Paracetamol and What Type of Medicine is it?

Austell-Paracetamol is defined as a foundational monocomponent drug that serves dual roles as a Non-opioid analgesic and an Antipyretic. This preparation, which is distributed in markets such as South Africa and typically supplied as an Over-The-Counter (OTC) medicine, is derived from the Aniline analgesic chemical group. The active substance, Paracetamol (Acetaminophen), is listed on the WHO Model List of Essential Medicines, underscoring its recognized importance in fundamental healthcare globally.

What is the Active Ingredient in Austell-Paracetamol?

The sole active ingredient in this preparation is Acetaminophen, the chemical substance universally known as Paracetamol (N-(4-hydroxyphenyl)ethanamide). Austell-Paracetamol is commonly presented in various standard dosage forms, including tablets, caplets, and oral suspension, determining the common route of administration, which is primarily oral. The compound is utilized for the clinical management of acute symptoms and is recognized for its rapid efficacy. The formulation uses standard pharmaceutical carriers to ensure consistent delivery of the Acetaminophen.

What is the General Purpose of Austell-Paracetamol?

The general purpose of Austell-Paracetamol is to alleviate mild-to-moderate pain—such as headaches or muscle aches—and facilitate the normalization of an elevated body temperature, or pyrexia. The medicine achieves this through a core mechanism acting primarily within the central nervous system (CNS), which differentiates its profile from peripherally-acting drugs. This centralized action on the body's thermoregulatory center provides relief by modulating the body's thermal set point and decreasing the perception of discomfort.

Regulatory References

  1. Paracetamol (acetaminophen) on eEML
  2. Acetaminophen (Paracetamol) Pharmacology
  3. Acetaminophen MedlinePlus Drug Information
Advertisements

What side effects are possible with Austell-Paracetamol?

Official Safety Profile and Adverse Reactions

The safety characteristics of Acetaminophen (Paracetamol) are formally structured in regulatory documents, defining possible adverse effects, frequency classifications, and patient-specific limitations. Adverse reactions are mostly documented as Rare or Very Rare at therapeutic doses, with the potential for more severe, albeit infrequent, events governing the overall safety profile.

System-Organ Classes and Serious Reactions

Regulatory labeling specifies adverse effects across several System-Organ Classes. The most critical focus areas include Hepato-biliary disorders, reflecting the potential for severe liver effects, and Skin and subcutaneous tissue disorders.

The most clinically significant and serious adverse reaction documented is Acute Liver Failure, a rare event at recommended doses, but one that is strictly emphasized in government safety warnings. Other serious reactions officially listed include Serious Skin Reactions, such as Stevens-Johnson syndrome (SJS), and Anaphylactic Shock, which are also rare but require immediate attention.

Population-Specific Safety Constraints

The official label defines specific safety constraints for certain patient groups. The medicine is contraindicated or requires caution in individuals with severe hepatic impairment or severe active liver disease. Increased risk of toxicity is also noted for patients with severe renal impairment and those with a history of chronic alcohol use. Safety documentation also highlights that prolonged, regular daily use may enhance the effect of some blood-thinning medicines.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Austell-Paracetamol is associated with a specific, time-dependent toxicity profile documented in regulatory labeling. Initial presentations may be non-specific, often involving Nausea, Vomiting, Malaise, and Anorexia; however, these do not reflect the full potential danger. The primary and most serious documented risk is delayed Hepatotoxicity (liver damage), which can progress to Acute Liver Failure and Death.

Immediate medical action is explicitly required by regulatory bodies. Individuals must seek immediate medical attention or emergency department evaluation, and contact a Poison Control Center, following any suspected overdose. This must be done regardless of the severity or presence of symptoms, due to the latency of the most severe effects.

The specific antidote, N-acetylcysteine (NAC), is required for treatment, and its efficacy is strictly time-dependent. Hospital monitoring is mandated to assess hepatic injury, which includes checking Plasma Acetaminophen Concentration (at least four hours post-ingestion) and performing Liver Function Tests (LFTs). Increased susceptibility to severe liver injury is documented for individuals with underlying hepatic impairment, chronic alcoholism, or chronic malnutrition.

Advertisements

Therapeutic Uses of Austell-Paracetamol

Austell-Paracetamol is generally applied across therapeutic domains to provide symptomatic relief and may assist in supporting comfort during periods of acute discomfort and illness. This medicine is commonly used to help with pain and fever.


Management of Fever and Systemic Aches

This medication may be used for managing symptoms related to elevated body temperature, known as pyrexia, which may be a frequent manifestation of systemic imbalance. It is applied in clinical settings that involve acute symptom patterns when fever contributes to generalized patient distress, often alongside infections like colds and flu. This is often relevant for managing fever in pediatric patients (children and infants) as part of supportive care. A primary therapeutic benefit is its role in managing symptoms related to systemic imbalance, helping ease the overall symptom burden experienced during acute phases of illness.

Relief of Mild-to-Moderate Pain (Analgesia)

Austell-Paracetamol may be used for managing various sources of mild-to-moderate pain. This domain includes common discomforts such as headaches, dental pain, musculoskeletal aches (e.g., in osteoarthritis or minor injuries), and cyclical pain like dysmenorrhea. Its application in these scenarios supports general well-being during symptomatic periods, offering support that may assist patients cope more steadily with temporary or episodic discomfort.


Quick Fact: Relief for Musculoskeletal Aches

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

Austell-Paracetamol (Acetaminophen) eligibility for use is strictly defined by official regulatory guidelines established by national health authorities.

Absolute Contraindications

Use of this medicine is absolutely prohibited (contraindicated) for individuals with a known hypersensitivity or allergy to paracetamol or any component of the preparation. It is also strictly contraindicated for patients diagnosed with Severe Hepatocellular Insufficiency or clinically active, decompensated liver disease.

Age- and Condition-Based Restrictions

The medicine is generally approved for use in Adults, Adolescents, and Children above the minimum established age for the specific formulation, but is typically not recommended for infants under one month of age. Use requires caution and is restricted in patients with Severe Renal Impairment or Mild-to-Moderate Hepatic Insufficiency, as well as individuals with pre-existing conditions such as chronic Alcoholism or severe Malnutrition.

Pregnancy and Lactation Eligibility

Regulatory status indicates that use during Pregnancy is permitted when clinically necessary, provided it is taken at the lowest effective dose for the shortest possible duration. The medicine is generally considered compatible with Breastfeeding when used at therapeutic doses.

Advertisements

What should I know about interactions with other medicines?

Austell-Paracetamol's interaction profile is officially documented by regulatory authorities, focusing on specific pharmacokinetic and pharmacodynamic effects. Co-administration with certain agents alters the absorption or clearance of the medicine. For instance, Metoclopramide and Domperidone are documented to accelerate its absorption rate, while the ion exchange resin Cholestyramine reduces absorption. To achieve the maximal effect, regulatory text indicates an administration separation of at least one hour is required when taking Cholestyramine.

Probenecid is officially documented to reduce Paracetamol clearance by approximately 50% through the inhibition of its conjugation pathway. Substances that induce hepatic microsomal enzymes, such as Phenytoin, Phenobarbital, or the herbal product St John's Wort, may increase the risk of Paracetamol hepatotoxicity, particularly in the context of overdose. This effect is also heightened in chronic alcohol users and individuals with risk factors for glutathione depletion.

A significant pharmacodynamic interaction exists with Warfarin and other oral coumarins; prolonged, regular daily use of Paracetamol can officially enhance the anticoagulant effect and increase the risk of bleeding. Furthermore, concurrent intake with Flucloxacillin has been associated with High Anion Gap Metabolic Acidosis (HAGMA) in patients with severe renal impairment or other defined risk factors.

Advertisements

Mechanism of Action

Austell-Paracetamol functions as an analgesic and antipyretic agent primarily through interaction within the central nervous system (CNS). The compound is classified as a non-opioid, non-salicylate compound. Its principal biological target is believed to be the inhibition of cyclooxygenase (COX) enzymes, particularly the COX-2 and a putative COX-3 isoform, which are responsible for the biosynthesis of prostanoids. This interaction type is crucial for its overall mechanism.

The inhibition of these COX enzymes effectively reduces the cellular conversion of arachidonic acid into prostaglandins (PGE2) within the CNS. This pathway modulation lowers the local concentration of these signaling molecules, which mediate cellular responses in temperature regulation and pain sensitization pathways. Austell-Paracetamol does not exhibit significant COX inhibition in peripheral tissues, which distinguishes its mechanism of action from that of peripheral non-steroidal anti-inflammatory drugs (NSAIDs).

By suppressing the synthesis of these central prostaglandins, the drug interferes with the intracellular signaling cascade that contributes to the activation of central pain receptors (nociceptors) and the resetting of the hypothalamic temperature set-point. The system-level physiological consequence of this mechanistic cascade is the modulation of central pain signaling and a reduction in core body temperature via an increase in peripheral heat dissipation.

Advertisements

Dosage and Administration Information

How to Use Austell-Paracetamol

The use of Austell-Paracetamol, containing the active ingredient Acetaminophen (Paracetamol), is governed by protocols that define specific administration, regardless of the dosage form. The medicine is primarily administered via the oral route as tablets, caplets, or suspensions, but is also available for rectal and intravenous (IV) infusion in clinical settings.

Official Dosing Regimens and Frequency

The standard oral dose for adults weighing 50 kg or more is typically 500 mg to 1000 mg per administration. Dosing is based on an intermittent schedule, which mandates a minimum interval of 4 hours between successive doses. The core principle of administration is strict adherence to a daily limit, with the maximum total dose from all paracetamol-containing products not to exceed 4000 mg (4 g) in a 24-hour period.

Administration Requirements

Oral forms may be administered with or without food. Liquid formulations require the use of a calibrated measuring device (syringe or cup) to ensure the dose measured is accurate. When the intravenous route is employed, the solution must be administered slowly as a 15-minute infusion under specialized care.

Population-Specific Use

Official instructions require specific dosing rules for certain patient groups. For pediatric patients, the dose is calculated proportionally based on body weight (typically 10 mg/kg to 15 mg/kg per dose). Furthermore, patients with severe renal impairment often require an extended minimum dosing interval of at least 6 to 8 hours to align with clearance considerations. Prolonged or frequent use beyond 3 to 5 days for acute symptoms is generally discouraged without subsequent medical re-evaluation. The administration protocol emphasizes that the total number of doses and the amount must be tightly controlled to remain within the stated daily ceiling.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus

Studies were designed to evaluate the drug's effect on pain levels and symptom severity. The exact mechanism by which paracetamol produces its analgesic and antipyretic (fever-reducing) effects is complex and continues to be investigated, but it is thought to involve actions primarily within the central nervous system (CNS), distinguishing it from traditional non-steroidal anti-inflammatory drugs (NSAIDs).


Core Clinical Trials

Several studies have evaluated the potential effect of paracetamol in individuals with various types of acute mild-to-moderate pain (such as headache, dental pain, and postoperative pain) and fever. These studies frequently include Randomized Controlled Trials (RCTs) and observational follow-ups. Research has investigated whether a reduction in pain and fever symptoms was maintained over a standard treatment period.

Key metrics evaluated in these studies commonly include:

  • Symptom Scoring: Examination of differences in standardized pain and sensation scores (e.g., VAS, pain rating scales) between the group receiving the drug and a comparator group (placebo or active drug).
  • Tolerability Profile: Collection of data on the types and frequency of side effects reported by participants, particularly concerning gastrointestinal and renal tolerability compared to other analgesics.

Combination Studies

A study evaluating paracetamol in combination with other analgesics (such as NSAIDs or opioids) examined whether this approach affected patient outcomes. The primary objective of these combination studies is typically to compare:

  1. The effect on pain reduction when the drug was investigated as part of a multimodal regimen.
  2. The overall tolerability and any opioid-sparing effect, which refers to the ability to reduce the total amount of opioid needed for pain management.

Key Studies & References

  1. Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) for the primary treatment of headache and migraine in adults: NICE Guideline
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Austell-Paracetamol (FAQ)

Q: What specific kinds of pain does Austell-Paracetamol help with?

Regulatory documents state that Austell-Paracetamol is indicated for the temporary relief of mild-to-moderate pain. This includes common types of discomfort such as headaches, backaches, muscle pain, dental pain, and general body aches often associated with cold and flu symptoms.


Q: How quickly does Austell-Paracetamol usually start working?

Official product information suggests that the onset of pain relief for oral formulations typically begins approximately 15 to 30 minutes after the medicine is taken. The time it takes to start working can sometimes be affected by factors like when food was last consumed.


Q: How long do the pain-relieving effects of Austell-Paracetamol last?

Studies and official information indicate that the analgesic (pain-relieving) effect of a single therapeutic dose is generally expected to last approximately 4 to 6 hours. This duration aligns with the recommended minimum interval between doses.


Q: Can Austell-Paracetamol cause stomach problems or nausea?

Nausea, vomiting, and abdominal pain are among the adverse effects reported in official documents for paracetamol. However, when the medicine is used at the recommended therapeutic doses, these gastrointestinal issues are generally considered uncommon or rare.


Q: Is it normal to feel a little drowsy after taking Austell-Paracetamol?

Regulatory documents list dizziness and headache as possible side effects. Drowsiness is not typically listed as a common or expected side effect for single-ingredient paracetamol. If unexpected side effects like drowsiness are experienced, the Patient Information Leaflet should be consulted.


Q: Does Austell-Paracetamol interact with any common over-the-counter cold medicines?

Regulatory guidance strictly cautions against taking Austell-Paracetamol with any other medicine that also contains paracetamol (acetaminophen). This is due to the potential risk of accidentally exceeding the maximum daily limit, as many cold and flu remedies also contain paracetamol.


Q: What should I avoid drinking or eating when taking Austell-Paracetamol?

Official information advises that chronic users of alcohol should exercise caution due to a heightened risk of liver toxicity. Also, taking the medicine with food may slow down how quickly it is absorbed by the body.


Q: Can Austell-Paracetamol be taken with basic supplements like vitamins?

Regulatory interaction profiles do not generally report that paracetamol is affected by basic dietary supplements or vitamins. However, official recommendations suggest that healthcare providers should be made aware of all medicines and supplements being used concurrently.


Q: Are there different strengths of Austell-Paracetamol available?

Yes, official regulatory information confirms that paracetamol is available in various strengths and dosage forms. These commonly include standard 500 mg tablets, as well as oral suspensions for children.


Q: Is Austell-Paracetamol a non-steroidal anti-inflammatory drug (NSAID)?

No, Austell-Paracetamol is officially classified as a non-opioid analgesic (pain reliever) and antipyretic (fever reducer). Unlike NSAIDs, it does not have significant anti-inflammatory activity in the peripheral parts of the body.


Q: What happens if you miss a dose of Austell-Paracetamol?

Regulatory instructions generally advise that if a dose is missed, it should be taken as soon as it is remembered. The recommended time interval between doses must be adhered to, in accordance with the official dosing guidelines.


Q: What are the signs of taking too much Austell-Paracetamol?

Symptoms of overdose are documented in regulatory warnings and can include initial signs such as nausea, vomiting, abdominal pain, and loss of appetite. Due to the potential for severe liver damage, any suspected overdose is regarded as a medical emergency and requires immediate professional evaluation, even if initial symptoms are not apparent.


Q: Can someone with high blood pressure safely use Austell-Paracetamol?

Regulatory documents list hypertension (high blood pressure) as a reported adverse event associated with regular use. Individuals with pre-existing high blood pressure are advised to seek guidance from a healthcare professional regarding its use.


Q: Are there long-term side effects associated with regular use of Austell-Paracetamol?

Official warnings state that prolonged, regular daily use may increase the risk of adverse effects related to the kidneys or liver. It can also enhance the effect of blood-thinning medicines, which is why chronic use without medical supervision is discouraged.


Q: Can Austell-Paracetamol be crushed or split if it's a tablet?

Regulatory guidance on dosage forms indicates that immediate-release tablets can often be crushed or split. However, extended-release or coated formulations should not be split or crushed, as this may compromise the medicine's designed release mechanism.


Q: Is there a generic version of Austell-Paracetamol?

Yes, regulatory authorities confirm that the active ingredient, paracetamol (acetaminophen), is the generic name. It is widely available under numerous brand names, all manufactured to meet the same official standards for quality and safety.


Q: Can elderly patients use Austell-Paracetamol without special precautions?

While the regulatory label does not strictly prohibit use in the elderly, caution is advised. Monitoring of renal (kidney) function may be necessary, particularly if the medicine is used on a long-term, regular basis.


Q: What are the common signs of an allergic reaction to Austell-Paracetamol?

Official warnings list serious skin reactions that require immediate medical attention. These can include initial signs such as skin reddening, rash, and blisters. Swelling of the face or throat, which suggests anaphylaxis, is also a serious, documented reaction.


Q: Why is paracetamol generally recommended over aspirin for certain individuals?

Regulatory overviews suggest that paracetamol is often preferred over aspirin, especially in children and individuals at risk of gastrointestinal bleeding. This is because paracetamol does not typically cause stomach irritation or significantly affect blood clotting.


Q: Are there specific symptoms where Austell-Paracetamol is not helpful?

Official documents state that the medicine is not effective against significant inflammation, as it acts primarily in the brain and spinal cord, not in peripheral tissues. The medicine should not be used if symptoms are not relieved by the recommended dose or if new, severe symptoms develop.


Q: Can Austell-Paracetamol be taken with cold drinks or juice?

Regulatory administration instructions state that oral formulations are generally advised to be taken with a glass of water. There are no specific restrictions against taking the medicine with cold drinks or juice.


Q: How does the action of Austell-Paracetamol differ from that of NSAIDs at a high level?

The key difference, as described in regulatory documents, is the site of action. Paracetamol acts predominantly in the Central Nervous System (CNS) to modulate pain and fever. In contrast, NSAIDs work in the peripheral body tissues, which gives them their anti-inflammatory effects that paracetamol lacks.


Q: Is it normal if Austell-Paracetamol takes longer to work sometimes?

Yes, pharmacokinetic data in official regulatory documents confirm that the rate of absorption and the time it takes for the effects to begin can be delayed. This delay is often observed if the medicine is taken with food.


Q: Does Austell-Paracetamol contain caffeine or other stimulants?

Single-ingredient Austell-Paracetamol does not contain caffeine or other stimulants, as listed in the official ingredients section. However, many combination products that include paracetamol do contain caffeine, and these are addressed in regulatory documents.


Q: Can Austell-Paracetamol be used for chronic pain (in general)?

Regulatory guidance strictly discourages the prolonged or frequent use of paracetamol for chronic symptoms without subsequent medical re-evaluation. Use is generally limited to short periods, such as 3 to 5 days, for acute symptoms.


Q: Is there an extended-release form of Austell-Paracetamol?

Yes, extended-release, or modified-release, formulations of paracetamol have been documented in regulatory sources. However, their availability and regulatory status may vary by region due to safety concerns regarding overdose management.


Q: How does the body process and eliminate Austell-Paracetamol?

Official pharmacokinetic information states that paracetamol is predominantly metabolized (broken down) in the liver. It is then eliminated from the body primarily through excretion by the kidneys.


Q: What evidence is there regarding Austell-Paracetamol's use in musculoskeletal pain?

Regulatory indications include musculoskeletal pain as one of the mild-to-moderate pain types for which the medicine is used. This refers to common discomforts like backache and general muscle aches.


Q: Can people with kidney issues generally use Austell-Paracetamol?

Use is strictly contraindicated or requires caution in individuals with severe kidney impairment. For patients with severe renal impairment, regulatory guidelines specify that a prolonged minimum dosing interval of at least 6 to 8 hours is necessary.


Q: Does Austell-Paracetamol contain any sugar or gluten?

Official regulatory documents list all inactive ingredients (excipients). While many tablets are generally formulated without sugar or gluten, patients are advised to check the specific formulation's Patient Information Leaflet to confirm the presence or absence of excipients like sorbitol or starch.


Q: Does Austell-Paracetamol interact with heart medications (general concern)?

Regulatory documents explicitly identify an interaction with specific heart-related medicines, such as the anticoagulant Warfarin. They state that prolonged, regular daily use of paracetamol can enhance Warfarin's blood-thinning effect.


Q: Does Austell-Paracetamol affect blood clotting?

Paracetamol is generally not considered a blood thinner at therapeutic doses and does not typically affect clotting directly. However, official warnings emphasize that prolonged, regular daily use can enhance the effect of prescribed anticoagulant medicines like Warfarin.

Advertisements

How should Austell-Paracetamol be stored and disposed of?

Storage and Disposal Requirements

All storage and disposal instructions for Austell-Paracetamol are strictly defined by regulatory documents to maintain product quality and safety.

Storage Requirement Specification
Temperature Store at or below 25 C
Protection Protect from light; keep securipack tightly closed
Container Store in the original package
Prohibited Environment Do not store in a bathroom
Stability Do not use after the printed expiry date
Child Safety Keep out of the sight and reach of children

Official Disposal

Regulatory instructions require that all unused or expired medicine be returned to a pharmacist. It is explicitly prohibited to dispose of the unused product in drains or sewerage systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Austell-Paracetamol found in:

A-Z Index: